HOOKIPA Pharma Inc.
NASDAQ:HOOK
1.895 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 20.129 | 14.249 | 18.448 | 19.584 | 11.942 | 7.629 | 0 |
| Cost of Revenue
| 3.552 | 3.602 | 4.64 | 53.133 | 46.312 | 21.965 | 0.398 |
| Gross Profit
| 16.577 | 10.647 | 13.808 | -33.549 | -34.37 | -14.336 | -0.398 |
| Gross Profit Ratio
| 0.824 | 0.747 | 0.748 | -1.713 | -2.878 | -1.879 | 0 |
| Reseach & Development Expenses
| 86.424 | 68.645 | 82.853 | 54.787 | 46.312 | 21.965 | 9.772 |
| General & Administrative Expenses
| 18.633 | 18.759 | 17.269 | 18.082 | 16.715 | 6.844 | 4.385 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 18.633 | 18.759 | 17.269 | 18.082 | 16.715 | 6.844 | 4.385 |
| Other Expenses
| 0 | -0.392 | -2.843 | 3.072 | 0.601 | 0.133 | -0.025 |
| Operating Expenses
| 117.823 | 87.404 | 100.122 | 72.869 | 63.027 | 23.197 | 12.088 |
| Operating Income
| -97.694 | -73.155 | -81.674 | -53.285 | -51.085 | -21.18 | -14.157 |
| Operating Income Ratio
| -4.853 | -5.134 | -4.427 | -2.721 | -4.278 | -2.776 | 0 |
| Total Other Income Expenses Net
| 16.482 | 8.47 | 6.01 | 9.203 | 8.048 | 4.967 | 1.438 |
| Income Before Tax
| -81.212 | -64.915 | -75.665 | -44.082 | -43.037 | -16.213 | -12.719 |
| Income Before Tax Ratio
| -4.035 | -4.556 | -4.102 | -2.251 | -3.604 | -2.125 | 0 |
| Income Tax Expense
| 0.368 | 0.23 | 0.001 | -10.281 | -8.89 | 0.024 | 0.004 |
| Net Income
| -81.58 | -64.915 | -75.665 | -44.082 | -43.037 | -16.237 | -12.723 |
| Net Income Ratio
| -4.053 | -4.556 | -4.102 | -2.251 | -3.604 | -2.128 | 0 |
| EPS
| -8.63 | -9.9 | -23 | -16.9 | -2.41 | -0.99 | -0.78 |
| EPS Diluted
| -8.63 | -9.9 | -23 | -16.9 | -2.41 | -0.99 | -0.78 |
| EBITDA
| -77.343 | -60.396 | -70.126 | -39.146 | -39.093 | -14.795 | -13.759 |
| EBITDA Ratio
| -3.842 | -5.134 | -4.427 | -2.721 | -4.278 | -1.939 | 0 |